GlassScriptPhysician profile
Alejandra R Grimsley
NPI 1558631226
$560.98
in general payments reported to CMS, 2019-2025
15 companies · $53.15 in 2025
The $53.15 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $68.15 · 2022: $131 · 2023: $79.30 · 2024: $229 · 2025: $53.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $108.73 | 2024 | Eluvia |
| Sumitomo Pharma America, INC. | $52.36 | 2024-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $47.10 | 2022-2024 | |
| Astellas Pharma US INC | $43.90 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $43.25 | 2021-2023 | |
| Coopersurgical, INC. | $35.87 | 2021-2024 | Paragard T 380a |
| Abbvie INC. | $35.09 | 2021 | |
| Organon LLC | $32.64 | 2022-2024 | Nexplanon |
| Pacira Pharmaceuticals Incorporated | $31.72 | 2022 | |
| Daiichi Sankyo INC. | $31.45 | 2022-2023 | Injectafer |
| Hologic Sales and Service, LLC | $25.59 | 2022-2023 | Affirm Prone Biopsy System |
| Myovant Sciences INC. | $24.97 | 2022 | |
| Evofem Biosciences, INC. | $17.52 | 2022 | |
| Exeltis, USA INC. | $17.48 | 2025 | Slynd |
| Myriad Women'S Health, INC. | $13.31 | 2023 | Myrisk |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandra Grimsley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.